EP1144441A3 - Disintegrin homologs - Google Patents

Disintegrin homologs

Info

Publication number
EP1144441A3
EP1144441A3 EP99933873A EP99933873A EP1144441A3 EP 1144441 A3 EP1144441 A3 EP 1144441A3 EP 99933873 A EP99933873 A EP 99933873A EP 99933873 A EP99933873 A EP 99933873A EP 1144441 A3 EP1144441 A3 EP 1144441A3
Authority
EP
European Patent Office
Prior art keywords
disintegrin
homologs
disintegrin homologs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99933873A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1144441A2 (en
Inventor
Paul O. Sheppard
Nand Baindur
Theresa A. Deisher
Paul D. Bishop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of EP1144441A2 publication Critical patent/EP1144441A2/en
Publication of EP1144441A3 publication Critical patent/EP1144441A3/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Surgery (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
EP99933873A 1998-07-10 1999-07-09 Disintegrin homologs Withdrawn EP1144441A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11388398A 1998-07-10 1998-07-10
US113883 1998-07-10
PCT/US1999/015638 WO2000002912A2 (en) 1998-07-10 1999-07-09 Disintegrin homologs

Publications (2)

Publication Number Publication Date
EP1144441A2 EP1144441A2 (en) 2001-10-17
EP1144441A3 true EP1144441A3 (en) 2001-11-28

Family

ID=22352096

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99933873A Withdrawn EP1144441A3 (en) 1998-07-10 1999-07-09 Disintegrin homologs

Country Status (7)

Country Link
EP (1) EP1144441A3 (ja)
JP (1) JP2002526033A (ja)
AU (1) AU4983399A (ja)
CA (1) CA2332311A1 (ja)
IL (1) IL140607A0 (ja)
WO (1) WO2000002912A2 (ja)
ZA (1) ZA200007766B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ506817A (en) 1998-02-11 2003-08-29 Immunex Corp Metalloprotease-disintegrin SVPH3-13 and SVPH3-17 nucleic acids, and their corresponding polypeptides and methods for their production
WO2001074857A2 (en) * 2000-04-03 2001-10-11 Bristol-Myers Squibb Company Methods and compositions for modulating integrin-mediated cell-cell interactions
US20020081685A1 (en) * 2000-08-03 2002-06-27 Fox Brian A. Disintegrin homologs, ZSNK10, ZSNK11, and ZSNK12

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9608130D0 (en) * 1996-04-19 1996-06-26 Univ Sheffield Adam proteins and uses thereof
JPH11155574A (ja) * 1997-12-01 1999-06-15 Eisai Co Ltd Ｍｄｃ遺伝子ファミリーに属する新規蛋白質およびそれをコードするｄｎａ
NZ506817A (en) * 1998-02-11 2003-08-29 Immunex Corp Metalloprotease-disintegrin SVPH3-13 and SVPH3-17 nucleic acids, and their corresponding polypeptides and methods for their production

Also Published As

Publication number Publication date
WO2000002912A2 (en) 2000-01-20
EP1144441A2 (en) 2001-10-17
IL140607A0 (en) 2002-02-10
AU4983399A (en) 2000-02-01
ZA200007766B (en) 2001-12-21
WO2000002912A3 (en) 2001-09-07
JP2002526033A (ja) 2002-08-20
CA2332311A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AU5290999A (en) Simplified window-raiser -
AU3522399A (en) Carvedilol-galenics
AU3437799A (en) City-car
AU3253699A (en) Myxochelines
AU5407599A (en) Sphingolipid-desaturase
AU8363398A (en) Capotasto
AU5998199A (en) New bis-benzimidazoles
EP0938928A3 (de) Brausen
AU2609599A (en) Sensor-coupling
EP1144441A3 (en) Disintegrin homologs
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU1055399A (en) Rollerboard
AU3347599A (en) Aeromobile
AU9347498A (en) Imidazotriazolopyrimidines
AU5223199A (en) Bathtub-bathseat
AU1912300A (en) Lipocalin homologs
AU2840799A (en) 1-phosphanorbornadienes
AU3819799A (en) Methoximinomethyloxathiazines
AU9218098A (en) Exocyclic-phosphoethanolamines
AU1779099A (en) Heterocyclyl-derivatives
AU4768799A (en) Bookcover
AUPP314598A0 (en) Shoe two

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

17P Request for examination filed

Effective date: 20010105

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

XX Miscellaneous (additional remarks)

Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20041220

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071214